Early Cardiac Toxicity Associated With Post-Transplant Cyclophosphamide in Allogeneic Stem Cell Transplantation-Reference-Cited by-同舟云学术

Early Cardiac Toxicity Associated With Post-Transplant Cyclophosphamide in Allogeneic Stem Cell Transplantation

Published:2021-06 Issue:2 Volume:3 Page:250-259
ISSN:2666-0873
Container-title:JACC: CardioOncology
language:en
Short-container-title:JACC: CardioOncology

Author:

Duléry Rémy,Mohty Razan,Labopin Myriam,Sestili Simona,Malard Florent,Brissot Eolia,Battipaglia Giorgia,Médiavilla Clémence,Banet Anne,Van de Wyngaert Zoé,Paviglianiti Annalisa,Belhocine Ramdane,Isnard Françoise,Lapusan Simona,Adaeva Rosa,Vekhoff Anne,Ledraa Tounes,Legrand Ollivier,Cohen Ariel,Bonnin Agnès,Ederhy Stéphane,Mohty Mohamad

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Oncology

Reference41 articles.

1. HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide;Luznik;Biol Blood Marrow Transplant,2008

2. Comparison of Outcomes of Hematopoietic Cell Transplants from T-Replete Haploidentical Donors Using Post-Transplantation Cyclophosphamide with 10 of 10 HLA-A, -B, -C, -DRB1, and -DQB1 Allele-Matched Unrelated Donors and HLA-Identical Sibling Donors: A Multivariable Analysis Including Disease Risk Index

3. Unmanipulated haploidentical transplants compared with other alternative donors and matched sibling grafts;Raiola;Biol Blood Marrow Transplant,2014

4. Is there a stronger graft-versus-leukemia effect using HLA-haploidentical donors compared with HLA-identical siblings?;Ringdén;Leukemia,2016

5. Comparison of outcomes after unrelated cord blood and unmanipulated haploidentical stem cell transplantation in adults with acute leukemia;Ruggeri;Leukemia,2015

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiac events occurring after allogeneic hematopoietic cell transplantation with post-transplant cyclophosphamide. Study conducted on behalf of the GETH-TC;Bone Marrow Transplantation;2024-09-14

2. Vascular biomarkers reveal a unique toxicity profile of posttransplant cyclophosphamide: secondary analysis of BMT CTN 0402 and 1202;Blood Vessels, Thrombosis & Hemostasis;2024-09

3. Outcomes of older adults undergoing allogeneic hematopoietic cell transplantation with post‐transplant cyclophosphamide based prophylaxis;European Journal of Haematology;2024-08-14

4. Cardiovascular Disease After Hematopoietic Stem Cell Transplantation in Adults;JACC: CardioOncology;2024-08

5. Cardiac Events Occurring after Allogeneic Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide. Study Conducted on Behalf of the GETH-TC;2024-07-26